ALKS 4230: a Novel Engineered IL-2 Fusion Protein with an Improved Cellular Selectivity Profile for Cancer Immunotherapy
Journal for ImmunoTherapy of Cancer（2020）
Key words
immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined